Novo Nordisk A/S: shareholders and insiders

NVONYSEHealthcare · Pharmaceutical Preparations

Price

$38.78

November 20, 2026Market cap $172B

What Ploutos Investor adds for Novo Nordisk A/S

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 7 fiscal years, from 2019
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors, from their own Form 4 filings.

Sorry, we do not have enough data

for purchases and sales by Novo Nordisk A/S's insiders

Why?

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

1 Holders over 5%Apr 23, 2025 Latest filing
  • BlackRock, Inc.Class B Stock
    Share of class5.20%

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Renaissance Technologies
    In the quarter+54%
  • Citadel Advisors (Griffin)
    In the quarter+413%
  • Millennium Mgmt (Englander)
    In the quarter+5.6%
  • Point72 (Cohen)
    In the quarter×10.9
  • Bridgewater (Dalio)
    In the quarter
  • D.E. Shaw
    In the quarter-92%
  • AQR Capital
    In the quarter-6.9%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 0.84% of its shares outstanding were held short, +18.4% since the report before.

Shares held short
37.44M
0.84%
Since the report before31.62M on Sep 30, 2026
+18.4%
3.1
12.05M
More days to cover thanof 4,578 US-listed companies with enough volume
36%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 4.43M
  • Nov 15, 2023: Shares held short 5.97M
  • Nov 30, 2023: Shares held short 5.60M
  • Dec 15, 2023: Shares held short 6.47M
  • Dec 29, 2023: Shares held short 5.75M
  • Jan 12, 2024: Shares held short 5.46M
  • Jan 31, 2024: Shares held short 7.52M
  • Feb 15, 2024: Shares held short 4.67M
  • Feb 29, 2024: Shares held short 4.88M
  • Mar 15, 2024: Shares held short 4.11M
  • Mar 28, 2024: Shares held short 2.83M
  • Apr 15, 2024: Shares held short 3.24M
  • Apr 30, 2024: Shares held short 3.64M
  • May 15, 2024: Shares held short 3.71M
  • May 31, 2024: Shares held short 4.48M
  • Jun 14, 2024: Shares held short 4.36M
  • Jun 28, 2024: Shares held short 4.52M
  • Jul 15, 2024: Shares held short 3.15M
  • Jul 31, 2024: Shares held short 4.05M
  • Aug 15, 2024: Shares held short 5.27M
  • Aug 30, 2024: Shares held short 5.13M
  • Sep 13, 2024: Shares held short 5.80M
  • Sep 30, 2024: Shares held short 7.03M
  • Oct 15, 2024: Shares held short 6.36M
  • Oct 31, 2024: Shares held short 6.05M
  • Nov 15, 2024: Shares held short 4.93M
  • Nov 29, 2024: Shares held short 5.68M
  • Dec 13, 2024: Shares held short 4.70M
  • Dec 31, 2024: Shares held short 8.30M
  • Jan 15, 2025: Shares held short 8.27M
  • Jan 31, 2025: Shares held short 13.57M
  • Feb 14, 2025: Shares held short 13.53M
  • Feb 28, 2025: Shares held short 13.51M
  • Mar 14, 2025: Shares held short 12.64M
  • Mar 31, 2025: Shares held short 14.66M
  • Apr 15, 2025: Shares held short 19.07M
  • Apr 30, 2025: Shares held short 25.12M
  • May 15, 2025: Shares held short 27.58M
  • May 30, 2025: Shares held short 33.67M
  • Jun 13, 2025: Shares held short 26.61M
  • Jun 30, 2025: Shares held short 25.70M
  • Jul 15, 2025: Shares held short 23.58M
  • Jul 31, 2025: Shares held short 20.76M
  • Aug 15, 2025: Shares held short 21.02M
  • Aug 29, 2025: Shares held short 25.78M
  • Sep 15, 2025: Shares held short 28.74M
  • Sep 30, 2025: Shares held short 31.46M
  • Oct 15, 2025: Shares held short 26.67M
  • Oct 31, 2025: Shares held short 28.24M
  • Nov 14, 2025: Shares held short 27.69M
  • Nov 28, 2025: Shares held short 29.59M
  • Dec 15, 2025: Shares held short 28.49M
  • Dec 31, 2025: Shares held short 32.38M
  • Jan 15, 2026: Shares held short 28.16M
  • Jan 30, 2026: Shares held short 31.69M
  • Feb 13, 2026: Shares held short 26.97M
  • Feb 27, 2026: Shares held short 28.26M
  • Mar 13, 2026: Shares held short 24.70M
  • Mar 31, 2026: Shares held short 19.93M
  • Apr 15, 2026: Shares held short 17.02M
  • Apr 30, 2026: Shares held short 14.00M
  • May 15, 2026: Shares held short 21.72M
  • May 29, 2026: Shares held short 22.68M
  • Jun 15, 2026: Shares held short 24.48M
  • Jun 30, 2026: Shares held short 27.78M
  • Jul 15, 2026: Shares held short 31.09M
  • Jul 31, 2026: Shares held short 29.42M
  • Aug 14, 2026: Shares held short 33.83M
  • Aug 31, 2026: Shares held short 31.65M
  • Sep 15, 2026: Shares held short 26.34M
  • Sep 30, 2026: Shares held short 31.62M
  • Oct 15, 2026: Shares held short 37.44M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading36.7% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 36.7% of the shares in the reported trades were short sales, against 39.9% in the 14 before.

Last 14 sessionsNov 2, 2026 – Nov 19, 2026
36.7%
The 14 beforeOct 13, 2026 – Oct 30, 2026
39.9%
Change
-3.2 pts
Short sales a dayon average, of 5.36M shares
1.97M
More than atof 3,666 US-listed companies, same days
13%
Median of alleight in ten from 34.5% to 63.8%
50.4%
  • Oct 13, 2026: Short sales 45.2%
  • Oct 14, 2026: Short sales 35.5%
  • Oct 15, 2026: Short sales 35.1%
  • Oct 16, 2026: Short sales 39.1%
  • Oct 19, 2026: Short sales 33.3%
  • Oct 20, 2026: Short sales 35.8%
  • Oct 21, 2026: Short sales 39.9%
  • Oct 22, 2026: Short sales 35.3%
  • Oct 23, 2026: Short sales 42.6%
  • Oct 26, 2026: Short sales 38.2%
  • Oct 27, 2026: Short sales 57%
  • Oct 28, 2026: Short sales 35.5%
  • Oct 29, 2026: Short sales 39.8%
  • Oct 30, 2026: Short sales 44.8%
  • Nov 2, 2026: Short sales 45.7%
  • Nov 3, 2026: Short sales 39.1%
  • Nov 4, 2026: Short sales 38.3%
  • Nov 5, 2026: Short sales 38.2%
  • Nov 6, 2026: Short sales 38%
  • Nov 9, 2026: Short sales 39.5%
  • Nov 10, 2026: Short sales 45.8%
  • Nov 11, 2026: Short sales 34.7%
  • Nov 12, 2026: Short sales 28%
  • Nov 13, 2026: Short sales 39.2%
  • Nov 16, 2026: Short sales 42.9%
  • Nov 17, 2026: Short sales 30.5%
  • Nov 18, 2026: Short sales 35.6%
  • Nov 19, 2026: Short sales 28.8%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

31 ETFs holding it5.37% The largest weight (PPH)
  • PPHVanEck Pharmaceutical ETF
    Weight in the fund5.37%
  • IXJiShares Global Healthcare ETF
    Weight in the fund1.99%
  • CGXUCapital Group International Focus Equity ETF
    Weight in the fund1.87%
  • EFGiShares MSCI EAFE Growth ETF
    Weight in the fund1.41%
  • IQLTiShares MSCI Intl Quality Factor ETF
    Weight in the fund1.12%
  • IEURiShares Core MSCI Europe ETF
    Weight in the fund0.95%
  • VGKVanguard European Stock Index Fund
    Weight in the fund0.94%
  • VYMIVanguard International High Dividend Yield Index Fund
    Weight in the fund0.79%
  • EFAiShares MSCI EAFE ETF
    Weight in the fund0.69%
  • JIREJPMorgan International Research Enhanced Equity ETF
    Weight in the fund0.66%

31 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

1,352 Managers, Q2 2026$15.7B Value of their positions
  • Q3 2025: Managers 1,398
  • Q4 2025: Managers 1,420
  • Q1 2026: Managers 1,280
  • Q2 2026: Managers 1,352

Institutional investors by quarter

The fund managers holding NVO, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 1,352 managers held 327M shares, worth $15.7B. During the quarter 213 opened a position, 141 closed one, 461 added and 452 trimmed.

The largest holders, Q2 2026

  • Dodge & Cox
    In the quarter+5.5%
  • Loomis Sayles & Co L P
    In the quarter+9.3%
  • Franklin Resources
    In the quarter-19%
  • Price T Rowe Associates
    In the quarter+5.8%
  • Morgan Stanley
    In the quarter+7.3%
  • Bank of America
    In the quarter+3.8%
  • Capital International Investors
    In the quarter-18%
  • Folketrygdfondet
    In the quarter+4.9%
  • Goldman Sachs Group
    In the quarter+79%
  • Fisher Asset Management
    In the quarter-7.7%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Novo Nordisk A/S's filings show?

Who buys and sells is one part of Novo Nordisk A/S's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about NVO's shareholders

Didn't find what you were looking for?

Ask us
Have NVO's insiders bought or sold?

From – to – Novo Nordisk A/S's insiders reported no purchase or sale of shares on the market.

Which well-known managers hold NVO?

7 of the managers we track held the shares on Sep 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $266M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.